Click Therapeutic Scores $52M in Series B

Click Therapeutic announced a $52 million Series B funding round, Mobi Health News reports. H.I.G. BioHealth Partners and Accelmed Partners ll led the round, with participation from Health Catalyst Capital, Revelation Partners, Sanofi, K2 HealthVentures, Hima Ventures and RdigetopHealth. 

This news comes over a year after the company inked a $500 million-plus deal with pharma company Boehringer Ingelheim to jointly commercialize a digital treatment for patients with schizophrenia. 

Click Therapeutic is focused on providing software as a prescription therapy for a number of conditions. The company got its start in smoking cessation, and quickly expanded to include other mental health conditions including major depressive disorder, insomnia and schizophrenia. Read more.

Total
0
Shares
Related Posts
Read More

Surgery Partners Closes $321M IPO

Headquartered in Brentwood, Tennessee, Surgery Partners is a healthcare services company with an outpatient delivery model for surgical and related ancillary care in support of both patients and physicians.